Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA ® 800 mg ( " Jonson & Jonson " , Russia)

Condition:   Bioequivalence Interventions:   Drug: GP30101;   Drug: Prezista® Sponsor:   Geropharm Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials